Ethyl Vanillin

Ethyl Vanillin

SCHEMBL367277

CC(O)CO.CCOC(C)OCC.CCOc1cc(C=O)ccc1O

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Ethyl Vanillin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.70
MEN1 O00255 7/20 0.50
KMT2A Q03164 7/20 0.50
TOP2A P11388 1/20 0.49
HPGD P15428 3/20 0.48
TRIM24 O15164 1/20 0.48
ALDH5A1 P51649 1/20 0.48
ABAT P80404 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
TRIM33 Q9UPN9 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.46
ALPI P09923 1/20 0.46
ALPG P10696 1/20 0.46
ABL1 P00519 1/20 0.45
ABCB1 P08183 1/20 0.45
BCR P11274 1/20 0.45
PIM1 P11309 2/20 0.44
PIM3 Q86V86 2/20 0.44
PIM2 Q9P1W9 2/20 0.44
KDM4E B2RXH2 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Vanillin SCHEMBL434399 1.00 ALDH1A1 (0.70) ALDH1A1MEN1KMT2ATOP2AHPGD
Ethyl Vanillin SCHEMBL11126388 0.94 ALDH1A1 (0.68) ALDH1A1MEN1KMT2ATOP2AHPGD
Ethyl Vanillin SCHEMBL9652067 0.94 ALDH1A1 (0.80) ALDH1A1MEN1KMT2ATOP2AHPGD
Ethyl Vanillin SCHEMBL891376 0.94 ALDH1A1 (0.80) ALDH1A1MEN1KMT2ATOP2AHPGD
Ethyl Vanillin SCHEMBL20873435 0.91 ALDH1A1 (0.76) ALDH1A1MEN1KMT2ATOP2AHPGD
Vanillin SCHEMBL118411 0.90 ALDH1A1 (0.62) ALDH1A1MEN1KMT2ATOP2AHPGD
Vanillin SCHEMBL4665586 0.90 ALDH1A1 (0.62) ALDH1A1MEN1KMT2ATOP2AHPGD
Vanillin SCHEMBL432750 0.90 ALDH1A1 (0.62) ALDH1A1MEN1KMT2ATOP2AHPGD
Ethyl Vanillin SCHEMBL10344524 0.89 ALDH1A1 (0.68) ALDH1A1MEN1KMT2ATOP2AHPGD
Ethyl Vanillin SCHEMBL28567316 0.89 ALDH1A1 (0.72) ALDH1A1MEN1KMT2ATOP2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 421 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118139794-A Membrane and capsule 联合利华知识产权控股有限公司 2024-06-04 CN claimed
EP-4356894-A1 SUSTAINABLE PRODUCT WITH MALODORS Beiersdorf AG (DE) 2024-04-24 EP claimed
EP-3494104-B1 WARMING SENSATION COMPOUNDS TAKASAGO PERFUMERY CO LTD (JP) 2023-11-15 EP claimed
CN-116439403-A Atomized liquid, atomizer and aerosol generating device 常州市派腾电子技术服务有限公司 2023-07-18 CN claimed
US-11504443-B2 Odor-modulating agent and odor-modulating method YAMAMOTO PERFUMERY CO., LTD. (JP) 2022-11-22 US claimed
CN-107407046-B Fibrous element, fibrous structure and product comprising a deterrent agent and methods of making the same 宝洁公司 2022-11-01 CN claimed
CN-114672359-A Lubricating oil 山本香料株式会社 2022-06-28 CN claimed
EP-3569671-B1 METHYLMENTHOL DERIVATIVE AND COOL-SENSATION IMPARTER COMPOSITION CONTAINING SAME TAKASAGO PERFUMERY CO LTD (JP) 2022-06-22 EP claimed
US-11344488-B2 Cool-sensation imparter composition containing 2,2,6-trimethylcyclohexanecarboxylic acid derivative TAKASAGO INTERNATIONAL CORPORATION (JP) 2022-05-31 US claimed
CN-110168038-B Methyl menthol derivative and cold sensate composition containing same 高砂香料工业株式会社 2022-05-27 CN claimed
CN-101346072-A Compositions for oral or transdermal delivery providing a heating sensation CADBURY ADAMS USA LLC (US) 2009-01-14 CN claimed
WO-2007092823-A2 SIALAGOGUE COATINGS FOR INTERPROXIMAL DEVICES WHITEHILL ORAL TECHNOLOGIES, INC. (US) 2007-08-16 WO claimed
US-20070190090-A1 SIALAGOGUE BASED ORAL CARE PRODUCTS WHITEHILL ORAL TECHNOLOGIES, INC. (US) 2007-08-16 US claimed
US-20060177384-A1 Sialagogue coatings for interproximal devices WHITEHILL ORAL TECHNOLOGIES, INC. 2006-08-10 US claimed
US-6899901-B2 Sensate composition imparting initial sensation upon contact TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-05-31 US claimed
US-6890567-B2 Sensate composition imparting initial sensation upon contact TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-05-10 US claimed
US-6780443-B1 COMBINATION OF COOLING, WARMING AND TINGLING AGENTS FOR SUCH AS MOUTHWASHES; EMPLOYS JAMBU OLEORESIN AND/OR SPILANTHOL; LONG LASTING TAKASAGO INTERNATIONAL CORPORATION (JP) 2004-08-24 US claimed
US-20040052735-A1 Sensate composition imparting initial sensation upon contact TAKASAGO INTERNATIONAL CORPORATION 2004-03-18 US claimed
US-20030215532-A1 New sensate composition imparting initial sensation upon contact TAKASAGO INTERNATIONAL CORPORATION 2003-11-20 US claimed
EP-1121927-A2 A composition causing different skin sensations Takasago International Corporation (JP) 2001-08-08 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070190090-A1 SIALAGOGUE BASED ORAL CARE PRODUCTS MUC1, TAS2R40, TAS2R39 ALDH1A1 3787/4885MEN1 4649/4885KMT2A 4366/4885
US-11344488-B2 Cool-sensation imparter composition containing 2,2,6-trimethylcyclohexanecarboxylic acid derivative CNR2, ADRB2, TRPA1 ALDH1A1 2031/4885MEN1 529/4885KMT2A 2365/4885
US-20040052735-A1 Sensate composition imparting initial sensation upon contact NISCH, OSBP, TRPA1 ALDH1A1 2316/4885MEN1 980/4885KMT2A 4155/4885
US-20030215532-A1 New sensate composition imparting initial sensation upon contact NISCH, OSBP, TRPA1 ALDH1A1 2579/4885MEN1 1363/4885KMT2A 4305/4885
US-20060177384-A1 Sialagogue coatings for interproximal devices TAS2R10, SIGLEC7, TAS2R16 ALDH1A1 3938/4885MEN1 4780/4885KMT2A 3457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.